EquityPanditβs Outlook for Sun PharmaΒ for the weekΒ (Β JanΒ 01, 2018Β βΒ Jan 05, 2018) :Β SUN PHARMA: SUN PHARMA closed the week on positive note gaining...
The US health regulator has accepted a new drug application (NDA) for an ophthalmic solution, which was filed by Sun Pharma’s wholly owned subsidiary. In...
US based subsidiary of Sun Pharma,Β Sun Pharmaceutical Industries Inc (SPII) has voluntarily recalled 2 lots of diabetes drug Riomet, due to microbial contamination. Riomet is...